معرفی
Katja Ferenz is a Junior Professor (Assistant Professor) at the Institute of Physiology, University of Duisburg-Essen, affiliated with the University Hospital Essen, Germany. Her research is centered on the development and application of perfluorocarbon-based artificial oxygen carriers (AOCs) in clinical and physiological contexts.
Her research interests include:
- Artificial oxygen carriers and blood substitutes
- Perfluorocarbon nanoemulsions and nanocapsules
- Organ preservation via ex-vivo machine perfusion
- Decompression sickness and diving medicine
- Drug delivery systems using albumin-based carriers
- Biocompatibility and toxicity of nanocarriers
- Applications in hemodilution and anemia models
Her recent publications (2019–2025) reflect a strong focus on translating nanocarrier technology into clinical applications, particularly in transplantation and critical care. Articles span topics such as kidney and heart perfusion, lyophilization for storage, peptide-based carriers, and combination therapies with metal complexes. The work is deeply interdisciplinary, combining pharmaceutical sciences, physiology, and materials engineering.
Selected scientific contributions include:
- Development of albumin-derived PFC nanocarriers
- Investigations into emulsification stability and shelf life
- Applications in normothermic organ perfusion
- Prevention of decompression sickness in animal models
- Innovative drug delivery platforms for poorly soluble compounds
She advises research associates and doctoral candidates, and her team collaborates across disciplines, including thoracic surgery, physiological chemistry, and nanomedicine. She is actively involved in teaching physiology and oxygen-related pathophysiology at the medical faculty.
حوزههای پژوهشی
